Bladder Cancer

Show Only Open Trials

A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma

  • Study Status: Open to Enrollment
  • Sponsor: Cancer and Leukemia Group B (CALGB); National Cancer Institute (NCI)
  • Disease Status and/or Stage: Advanced Transitional Cell Carcinoma

A Phase I Study of 177Lu Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-591) in Patients with Nonprostate Metastatic Solid Tumors: A Pilot Study

  • Study Status: Open to Enrollment
  • Sponsor: Weill Cornell Medical College
  • Disease Status and/or Stage: Metastatic Solid Tumor

Top of page